Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

NCT01176461 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1
BIOLOGICAL: NY-ESO-1
BIOLOGICAL: gp100:209-217(210M)
BIOLOGICAL: gp100:280-288(288V)
DRUG: Montanide ISA 51 VG
BIOLOGICAL: BMS-936558

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]
[object Object]